Navigation Links
RPS Announces Jonathan M. Fishbein, MD as Executive Vice President and Chief Medical Officer
Date:11/13/2012

FORT WASHINGTON, Pa., Nov. 13, 2012 /PRNewswire/ -- ReSearch Pharmaceutical Services, Inc. (RPS), a next generation CRO that provides comprehensive global Phase 1-4 clinical development solutions to the biopharmaceutical and medical device industries, today announced that Jonathan M. Fishbein, M.D. has joined the organization as Executive Vice President and Chief Medical Officer. 

In his role, he will have the responsibility of providing leadership and strategic direction to the Medical, Safety, and Medical Writing departments.  Dr. Fishbein has extensive experience in the planning and execution of clinical research in a broad range of therapeutic areas.

Dr. Fishbein joins RPS having recently served as a Vice President in several medical and scientific capacities at ICON Clinical Research.

Dr. Fishbein has over 20 years experience in clinical and basic research, working in the CRO industry, as well as the Government, academic and non-profit sectors.  Before joining ICON, he simultaneously held the positions of Special Assistant to the Deputy Director of the National institute of Allergy and Infectious Diseases (NIAID) and Senior Fellow at the International Center for Research on Women. Prior to those positions, he served as the first Director of the Office for Policy in Clinical Research Operations (OPCRO) at the NIAID's Division of AIDS.  In that role, Dr. Fishbein enforced compliance with regulations, guidance and policies to assure that federally-funded clinical research in HIV/AIDS met established standards of quality, integrity and ethics to protect the safety, rights, and confidentiality of human research subjects.

Before government service, he held various roles at PAREXEL International Corporation, including Vice President of North American Medical Services.

A surgeon by training, Dr. Fishbein was a Medical Staff Fellow at the National Cancer Institute (Immunology Branch) and a Fellow in Transplantation Immunology at the Transplantation Biology Research Center at the Massachusetts General Hospital/Harvard Medical School.  

"Jonathan brings significant expertise to RPS, and we are extremely pleased to welcome him as a member of our Executive Management Team. His addition builds on the depth and breadth of our strategic medical affairs leadership, and allows RPS to continue the growth of our global drug safety organization," said Alan Morgan, Chief Operating Officer.

About RPS

RPS provides comprehensive global Phase I-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries.  By combining our highly experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions. These solutions range from globally Embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project teams providing innovative, seamless, cost-effective and high quality services.

With more than 5,000 employees, RPS operates in more than 64 countries across the globe.


'/>"/>
SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
2. Developmental Disabilities Software announces Safe Harbor Self-Certification Compliance
3. Hologic Announces Fourth Quarter and Fiscal 2012 Operating Results
4. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
5. Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice
6. Cynosure, Inc. Announces Proposed Public Offering of Class A Common Stock
7. 3SBio Inc. Announces Unaudited Third Quarter 2012 Results
8. Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November
9. FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
10. Telik Announces Third Quarter 2012 Financial Results
11. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
(Date:8/3/2017)... , Aug. 3, 2017  Opioid addiction and other ... up healthcare costs and threatening outcomes, were problems taken ... and IVD industry that support them, met this week. ... researcher said that drugs of abuse, procalcitonin and acute ... at the organization,s 69th meeting in San ...
Breaking Medicine Technology:
(Date:8/23/2017)... ... 2017 , ... Drs. Steven White and Brad Haines are pleased to announce ... of this offer, valued at more than $300 per year, new patients can enjoy ... patients receive a complimentary professional whitening procedure. , Stained or yellowed tooth enamel ...
(Date:8/23/2017)... ... 2017 , ... Nightingale College continues the semiannual Give Back Day tradition for ... College dedicates to serving and volunteering for organizations that provide indispensable resources to the ... that need a little extra help. , The College’s Give Back Day initiative ...
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, the nation's ... the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. MobilityWorks ... percent, marking the twelfth year that the company has been included on the ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... (SNAC) is holding an inaugural State of the Science Symposium in partnership ... Wednesday, Sept. 20, 2017. , This symposium provides a forum for global leaders ...
(Date:8/22/2017)... NASHVILLE, Tenn. (PRWEB) , ... August 22, 2017 ... ... Company, is pleased to announce the addition of Zack Tisch as the ... services for the KLAS-ranked healthcare IT consulting firm’s national accounts, from assisting clients ...
Breaking Medicine News(10 mins):